Wei Phin Tan

Dr. Wei Phin Tan

NYU Langone Health, New York, NY, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
TCTimothy I. Carter
Timothy I. Carter
ZFZhi Ven Fong
Zhi Ven Fong
THTerry Hyslop
Terry Hyslop
HLHarish Lavu
Harish Lavu
WTWei Phin Tan
Wei Phin Tan
ERErnest L. Rosato
Ernest L. Rosato

1 April 2016 in Annals of Surgery
Verified
Journal Article
Closed access
JWJordan M. Winter
Jordan M. Winter
WJWei Jiang
Wei Jiang
Olca BasturkOlca Basturk
Olca Basturk
MMMari Mino-Kenudson
Mari Mino-Kenudson
ZFZhi Ven Fong
Zhi Ven Fong
PAPeter J. Allen
Peter J. Allen
Background: Early invasive carcinoma may be encountered in association with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. The natural history of these early invasive lesions is unknown. Methods: Pancreatic surgical databases from 4 high-volume centers were queried for IPMNs, with invasive components measuring 20 mm or less. All cases were reviewed by GI gastrointestinal pathologists, and pathologic features were analyzed to identify predictors of recurrence and survival. Results: A total of 70 small IPMN-associated invasive carcinomas (≤20-mm invasion) were identified, comprising 25% of resected IPMN-associated carcinomas (n = 280). Most of these small invasive cancers were multifocal (66%), less than 10 mm in size (73%), and arose in the setting of a main duct IPMN (96%). The most common adenocarcinoma subtypes were tubular (57%) and colloid (29%). Lymph node metastases were present in 19% of cases and 23% were T3 lesions. The overall recurrence rate was 24% (n = 17), and the median time to recurrence was 16 months (range: 4–132 months). Median and 5-year survival rates were 99 months and 59%. Recurrence patterns of invasive disease were local in 35%, distant in 47%, and both in 18%. Lymphatic spread and T3 stage were predictive of recurrence (univariate, P = 0.006), whereas tubular carcinoma type was the most predictive of poor overall survival (multivariate hazard ratio = 3.7, P = 0.04). Conclusions: This study represents the largest multi-institutional experience of resected small IPMN-associated carcinoma. Although these malignancies may frequently be cured with resection, recurrence risk is significant. Lymphatic spread, increased T stage, and tubular type carcinoma were associated with the poorest outcome.

3 September 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CNChirk Jenn Ng
Chirk Jenn Ng
CTChin Hai Teo
Chin Hai Teo
NANurdiana Abdullah
Nurdiana Abdullah
WTWei Phin Tan
Wei Phin Tan
HTHui Meng Tan
Hui Meng Tan
Cancer incidence and mortality varies across region, sex and country’s economic status. While most studies focused on global trends, this study aimed to describe and analyse cancer incidence and mortality in Asia, focusing on cancer site, sex, region and income status. Age-standardised incidence and mortality rates of cancer were extracted from the GLOBOCAN 2012 database. Cancer mortality to incidence ratios (MIRs) were calculated to represent cancer survival. The data were analysed based on the four regions in Asia and income. Cancer incidence rate is lower in Asia compared to the West but for MIR, it is the reverse. In Asia, the most common cancers in men are lung, stomach, liver, colorectal and oesophageal cancers while the most common cancers in women are breast, lung, cervical, colorectal and stomach cancers. The MIRs are the highest in lung, liver and stomach cancers and the lowest in colorectal, breast and prostate cancers. Eastern and Western Asia have a higher incidence of cancer compared to South-Eastern and South-Central Asia but this pattern is the reverse for MIR. Cancer incidence rate increases with country income particularly in colorectal and breast cancers but the pattern is the opposite for MIR. This study confirms that there is a wide variation in cancer incidence and mortality across Asia. This study is the first step towards documenting and explaining the changing cancer pattern in Asia in comparison to the rest of the world.

1 September 2013 in Journal of Surgical Research
Verified
Journal Article
Closed access
WTWei Phin Tan
Wei Phin Tan
VTVanessa A. Talbott
Vanessa A. Talbott
QLQi Quan Leong
Qi Quan Leong
GIGerald A. Isenberg
Gerald A. Isenberg
SGScott D. Goldstein
Scott D. Goldstein

1 December 2016 in Urology
Verified
Journal Article
Closed access
WTWei Phin Tan
Wei Phin Tan
CLCarol Lin
Carol Lin
MCMeri Chen
Meri Chen
LDLeslie A. Deane
Leslie A. Deane

1 January 2016 in Asian Journal of Andrology
Verified
Journal Article
Open access
LLLaurenceA Levine
LaurenceA Levine
WTWei Phin Tan
Wei Phin Tan
Post-vasectomy pain syndrome remains one of the more challenging urological problems to manage. This can be a frustrating process for both the patient and clinician as there is no well-recognized diagnostic regimen or reliable effective treatment. Many of these patients will end up seeing physicians across many disciplines, further frustrating them. The etiology of post-vasectomy pain syndrome is not clearly delineated. Postulations include damage to the scrotal and spermatic cord nerve structures via inflammatory effects of the immune system, back pressure effects in the obstructed vas and epididymis, vascular stasis, nerve impingement, or perineural fibrosis. Post-vasectomy pain syndrome is defined as at least 3 months of chronic or intermittent scrotal content pain. This article reviews the current understanding of post-vasectomy pain syndrome, theories behind its pathophysiology, evaluation pathways, and treatment options.